APRIL 22, 2026 • San Francisco

City View at Metreon

WHAT IS
UNLOCK 2026?

UNLOCK 2026 is a one-day only summit on April 22nd in San Francisco, focused on how AI is changing drug discovery and life sciences.

Through keynote talks and expert panels, Unlock creates a forum for substantive discussion about where AI is genuinely advancing biological research and where challenges remain.

Speakers include EVPs and SVPs from major pharma companies, founders and builders from the leading AI-bio companies, and researchers from top labs.

JOIN US TO EXPLORE WHAT’S NEXT AND HELP SHAPE IT.

AI Science: Cutting Through the Hype

• AI Science: Cutting Through the Hype •

OUR SPEAKERS

AVIV REGEV

Executive Vice President • Genentech

MICHELLE LEE

Founder & CEO • Medra

DAVID BAKER

Director, Institute for Protein Design & 2024 Nobel Laureate in Chemistry • University of Washington

PEYTON GREENSIDE

Co-Founder & CEO • BigHat Biosciences

RON ALFA

Co-Founder & CEO • Noetik

JEREMY ELSER, PhD

Head of Science Operations • Palantir

RESHMA SHETTY

Co-Founder & COO • Ginkgo Bioworks

HENRY LEE

CEO • Cultivarium

ALEX MORGAN

Partner • Khosla Ventures

MARTIN JENSEN

Co-founder & CSO • Gordian Biotechnologies

SARAH NAM

VP, Strategy and Partnerships • AbbVie

ANNA MARIE WAGNER

Co-founder & CEO • Transfyr

ARCHA JAIN

Head of Life Sciences • Goodfire

JONAH COOL

Life Sciences • Anthropic

JACOB KIMMEL

Co-founder & President • NewLimit

BO WANG

SVP & Head of Biomedical AI • Xaira Therapeutics

CI CHU

SVP, AI-Enabled Discovery • Xaira Therapeutics

ANDREW WHITE

Co-Founder & Head of Science • FutureHouse

SHAHIN FARSHCHI

Partner • Lux Capital

SAMUEL STANTON

Co-founder & Member of Technical Staff • Coefficient Bio

JOSEPH KRAUSE

Co-founder & CEO • Radical AI

JORGE REIS-FILHO

Chief AI Officer • AstraZeneca

PAYAL SHETH

SVP, Therapeutic Discovery Sciences • Bristol Meyers Squibb

CARINA HONG

Founder & CEO • Axiom Math

PETE FLORENCE

Co-Founder & CEO • Generalist

CHRIS LEITER

Investor • Atria Ventures

FAQ

Unlock is an invite-only, one-day summit on April 22, 2026 in San Francisco, focused on how AI is changing drug discovery and life sciences.

Through keynote talks and expert panels, Unlock creates a forum for substantive discussion about where AI is genuinely advancing biological research and where challenges remain.

Speakers include EVPs and SVPs from major pharma companies, founders and builders from the leading AI-bio companies, and researchers from top labs.

Join us to explore what’s next and help shape it.
April 22, 2026
City View at Metreon
135 4th St
San Francisco, CA
Yourself, a colleague, a laptop or tablet for live demos and business cards for networking—the rest is on us.
Photography, video, and audio recording may take place throughout the conference for documentation, promotional, and educational use. By attending Unlock 2026, you acknowledge and consent to the possibility of being captured in event media.
If you prefer not to be photographed or recorded, please notify event organizers in advance or speak with staff on site so reasonable efforts can be made to accommodate your request.
Yes. Lunch and Reception. A variety of dietary needs will be covered however, if you have a specific need you are concerned about please reach out to us at Unlock@medra.ai
Unfortunately, no animals are allowed at the event, with the exception of licensed service animals.